BioCentury
ARTICLE | Clinical News

Pivanex Injection: Began Phase Ib trial of safety and tolerability, antitumor activity, and evidence of apoptosis in tumors in 20 to 30 patients. Pivanex is a r

October 30, 1995 8:00 AM UTC

Ansan Inc. (ANSNU), Menlo Park, Calif. Product: Pivanex Injection, small molecule compound Indication: Refractory solid tumors Status: Began Phase Ib trial of safety and tolerability, antitumor activi...